PMID: 15237116Jul 9, 2004Paper

Cementless total hip arthroplasty using an autograft of the femoral head for marked acetabular dysplasia: case series

Journal of Orthopaedic Surgery
T YamaguchiK Shiramizu

Abstract

To assess the short-term outcome of cementless total hip arthroplasty involving an autograft of the femoral head in Japanese patients. Cementless total hip arthroplasty with autogenous bone block grafting was performed on 18 hips in 15 patients with marked acetabular dysplasia. The resected femoral head was used as a graft for the superior-lateral region of the true acetabulum. Clinical outcome was correlated with the placement of the acetabular component, as revealed in radiographs. The 13 women and 2 men had a mean age of 60.2 years (range, 37.0-73.0 years) at primary surgery and a mean follow-up duration of 3.3 years (range, 2.0-5.3 years). According to the classification of Crowe, 4 hips were in group I, 3 were in group II, one in group III, and 10 in group IV. The mean Harris Hip Score preoperatively was 45.7 (range, 19-69) and that at follow-up was 82.5 (range, 44-100). All 15 cases showed a good clinical outcome. There were no major intra-operative complications in this series. The grafted bones united in all patients. Two patients need surgical revision because the lateral insertion of the acetabular component resulted in loosening of it. Medial insertion of the acetabular component provides satisfactory short-term outc...Continue Reading

Citations

Jan 26, 2006·The Journal of Bone and Joint Surgery. British Volume·P T de JongR K Marti
Jun 4, 2013·European Journal of Orthopaedic Surgery & Traumatology : Orthopédie Traumatologie·János SzabóZoltán Csernátony
May 21, 2014·Archives of Orthopaedic and Trauma Surgery·Domagoj DelimarGoran Bicanic

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.